logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 1
  • 1
    Boateng, Genevieve Boatemaa
    Born in November 1991
    Individual (7 offsprings)
    Officer
    2023-05-31 ~ now
    OF - Director → CIF 0
    Boateng, Genevieve
    Individual (7 offsprings)
    Officer
    2023-05-31 ~ now
    OF - Secretary → CIF 0
    Miss Genevieve Boatemaa Boateng
    Born in November 1991
    Individual (7 offsprings)
    Person with significant control
    2023-05-31 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
parent relation
Company in focus

GENPHARM LTD

Period: 2025-01-16 ~ now
Company number: 14906078
Registered names
GENPHARM LTD - now
Standard Industrial Classification
82990 - Other Business Support Service Activities N.e.c.
70229 - Management Consultancy Activities Other Than Financial Management
86210 - General Medical Practice Activities
Brief company account
Turnover/Revenue
4,679 GBP2024-06-01 ~ 2025-05-31
0 GBP2023-05-31 ~ 2024-05-31
Gross Profit/Loss
4,679 GBP2024-06-01 ~ 2025-05-31
0 GBP2023-05-31 ~ 2024-05-31
Administrative Expenses
-4,690 GBP2024-06-01 ~ 2025-05-31
Operating Profit/Loss
-11 GBP2024-06-01 ~ 2025-05-31
0 GBP2023-05-31 ~ 2024-05-31
Profit/Loss on Ordinary Activities Before Tax
-11 GBP2024-06-01 ~ 2025-05-31
0 GBP2023-05-31 ~ 2024-05-31
Profit/Loss
-11 GBP2024-06-01 ~ 2025-05-31
0 GBP2023-05-31 ~ 2024-05-31
Total Inventories
1 GBP2024-05-31
Cash at bank and in hand
1,302 GBP2025-05-31
Current Assets
1,302 GBP2025-05-31
1 GBP2024-05-31
Net Current Assets/Liabilities
1,302 GBP2025-05-31
1 GBP2024-05-31
Total Assets Less Current Liabilities
1,302 GBP2025-05-31
1 GBP2024-05-31
Net Assets/Liabilities
1,302 GBP2025-05-31
1 GBP2024-05-31
Equity
Called up share capital
1 GBP2025-05-31
1 GBP2024-05-31
Retained earnings (accumulated losses)
1,301 GBP2025-05-31
Equity
1,302 GBP2025-05-31
1 GBP2024-05-31
Average Number of Employees
12024-06-01 ~ 2025-05-31
02023-05-31 ~ 2024-05-31

  • GENPHARM LTD
    Info
    THE COLLECTIVE ENTERPRISE GLOBAL LTD - 2025-01-16
    Registered number 14906078
    128 City Road, London EC1V 2NX
    PRIVATE LIMITED COMPANY incorporated on 2023-05-31 (2 years 11 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2025-05-30
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.